Evgenideion Hospital, Unit of Endocrinology, Diabetes and Metabolism, University of Athens, 11528, Athens, Greece.
Cardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore, Singapore.
Endocrine. 2019 Oct;66(1):63-69. doi: 10.1007/s12020-019-02067-9. Epub 2019 Sep 3.
The global population is aging with millions of people today living into their 90 s. Thyroid disease, particularly hypothyroidism, is widespread among all age groups, and it is expected to steadily increase as the population gets older. Clinical diagnosis of hypothyroidism is challenging, as the TSH reference range needs to be evaluated according to age, while evaluation of TSH levels must also take into account body weight and other variants such as polypharmacy, comorbidities, and general health condition. Since thyroid hormone has a potent regulatory effect on cholesterol metabolism, the possibility of thyroid dysfunction should be considered in cases of unexplained dyslipidemia. Once hypothyroidism has been confirmed, treatment requires caution, frequent cardiovascular monitoring, and individualized (precision) medicine. Treatment of subclinical hypothyroidism (SCH) in the elderly should be undertaken with care, guided by age and the degree of SCH: a TSH higher than 10 mU/l seems a reasonable threshold, though it should be regularly re-evaluated, while the LT4 dose needs to be tailored, taking into account the patient's health condition and the potential presence of dyslipidemia as well as other metabolic derangements.
全球人口正在老龄化,如今有数百万人已经进入 90 多岁的高龄。甲状腺疾病,特别是甲状腺功能减退症,在所有年龄段都很普遍,并且随着人口老龄化,预计其发病率将稳步上升。甲状腺功能减退症的临床诊断具有挑战性,因为 TSH 的参考范围需要根据年龄进行评估,而 TSH 水平的评估还必须考虑体重和其他变量,如多药治疗、合并症和整体健康状况。由于甲状腺激素对胆固醇代谢有很强的调节作用,在不明原因的血脂异常的情况下,应考虑甲状腺功能障碍的可能性。一旦确诊甲状腺功能减退症,治疗就需要谨慎,经常进行心血管监测,并采用个体化(精准)医学。对于老年人的亚临床甲状腺功能减退症(SCH)的治疗应慎重进行,应根据年龄和 SCH 的严重程度进行指导:TSH 高于 10mU/L 似乎是一个合理的阈值,但应定期重新评估,而 LT4 剂量需要根据患者的健康状况以及潜在的血脂异常和其他代谢紊乱情况进行调整。